The present study suggests anti-MUC4-IR800 labeling can be used to better identify liver metastasis and peritoneal metastatic pancreatic cancers from surrounding normal tissues and improve operative staging for patients with pancreatic cancer. The gene discussed is MUC4; the disease is pancreatic neoplasm.